Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
The net profit margin is N/A as of Tuesday, October 6, 2026.
NET PROFIT MARGIN
N/A
Market Cap
$83.96M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$84.70M
Net Profit Margin
-269.42%
TTM Avg
-19.58%
3Y Avg
-904.79%
5Y Avg
-881.91%
Market Cap
$84.75M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$81.22M
Net Profit Margin
-648.32%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$86.69M
Net Profit Margin
6.21%
TTM Avg
8.02%
3Y Avg
-5.41%
5Y Avg
-4.66%
Market Cap
$87.86M
Net Profit Margin
-7884.06%
TTM Avg
-7191.86%
3Y Avg
-8225.67%
5Y Avg
-7676.39%
Market Cap
$91.33M
Net Profit Margin
-39.96%
TTM Avg
-45.40%
3Y Avg
-116.56%
5Y Avg
-242.44%
Market Cap
$91.68M
Net Profit Margin
0.00%
TTM Avg
-9.81%
3Y Avg
-113.18%
5Y Avg
-75.45%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Conexeu Sciences Inc. (CNXU) | $83.49M | N/A | N/A | N/A | N/A |
| Cognition Therapeutics, Inc. (CGTX)vs › | $83.96M | 0.00% | 0.00% | 0.00% | 0.00% |
| Atara Biotherapeutics, Inc. (ATRA)vs › | $84.70M | -269.42% | -19.58% | -904.79% | -881.91% |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $84.75M | 0.00% | 0.00% | 0.00% | 0.00% |
| Citius Oncology, Inc. (CTOR)vs › | $81.22M | -648.32% | 0.00% | 0.00% | 0.00% |
| CareCloud, Inc. (CCLD)vs › | $86.69M | 6.21% | 8.02% | -5.41% | -4.66% |
| Cardiff Oncology, Inc. (CRDF)vs › | $87.86M | -7884.06% | -7191.86% | -8225.67% | -7676.39% |
| electroCore, Inc. (ECOR)vs › | $91.33M | -39.96% | -45.40% | -116.56% | -242.44% |
| Equillium, Inc. (EQ)vs › | $91.68M | 0.00% | -9.81% | -113.18% | -75.45% |
| Biomea Fusion, Inc. (BMEA)vs › | $93.99M | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Margin
N/A
Net Profit Margin
N/A
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
